000 | 01919 a2200529 4500 | ||
---|---|---|---|
005 | 20250517034402.0 | ||
264 | 0 | _c20150914 | |
008 | 201509s 0 0 eng d | ||
022 | _a1096-0333 | ||
024 | 7 |
_a10.1016/j.taap.2015.05.020 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aScherzberg, Maria-Christina | |
245 | 0 | 0 |
_aStructural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action. _h[electronic resource] |
260 |
_bToxicology and applied pharmacology _cAug 2015 |
||
300 |
_a67-76 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xgenetics |
650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
650 | 0 | 4 | _aCaco-2 Cells |
650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aColonic Neoplasms _xgenetics |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHT29 Cells |
650 | 0 | 4 | _aHep G2 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Neoplasms _xgenetics |
650 | 0 | 4 |
_aMicrotubules _xdrug effects |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 | _aResveratrol |
650 | 0 | 4 |
_aSirtuin 1 _xgenetics |
650 | 0 | 4 |
_aStilbenes _xchemistry |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 |
_aTubulin Modulators _xpharmacology |
700 | 1 | _aKiehl, Andreas | |
700 | 1 | _aZivkovic, Aleksandra | |
700 | 1 | _aStark, Holger | |
700 | 1 | _aStein, Jürgen | |
700 | 1 | _aFürst, Robert | |
700 | 1 | _aSteinhilber, Dieter | |
700 | 1 | _aUlrich-Rückert, Sandra | |
773 | 0 |
_tToxicology and applied pharmacology _gvol. 287 _gno. 1 _gp. 67-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2015.05.020 _zAvailable from publisher's website |
999 |
_c24953249 _d24953249 |